At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Nucleus 6 Sound Processordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigation of Nucleus 6 Sound Processor Input Processing in Cochlear Implant Recipients.
In Brief
A clinical study evaluating Nucleus 6 Sound Processor for Hearing Loss. Completed, enrolled 40 participants across 4 sites.
Detailed Summary
The purpose of this study is to evaluate the enhanced signal processing features of the Nucleus 6 Sound Processor on existing Nucleus cochlear implant recipients currently using the Nucleus 5 Sound Processor.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMay 2014
First PostedSep 2014
Primary CompletionNov 2014
Study CompletionJan 2015
TodayJul 2026
First PostedSep 12, 2014
Enrollment StartMay 1, 2014
Primary CompletionNov 1, 2014
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.8 years ago
Interventions
Nucleus 6 Sound Processordevice